Purpose: Pulmonary hypertension is a known risk factor for mortality in preterm infants with bronchopulmonary dysplasia. However, mortality in patients with bron chopulmonary dysplasia and congenital heart disease has been poorly investigated. Therefore, we conducted an investigation into the mortality and risk factors in these patients. Methods: We reviewed the records of 45 preterm infants who were diagnosed with bronchopulmonary dysplasia and congenital heart disease from 2010 to 2013. Their survival was compared with that of a group of control individuals who did not have congenital heart disease. A variety of factors associated with survival were examined. Results: Although initial pulmonary hypertension was more frequent in the patient group, no significant differences were found between the patients and the control subjects with respect to cumulative mortality. The logrank test indicated that many factors, including followup pulmonary hypertension, the use of pulmonary vaso dilators, and aggravated oxygen demand, but not the congenital heart disease type, impacted upon survival in the patient group. Aggravated oxygen demand was the only factor that was determined to be associated with mortality in the multivariate analysis. Conclusion: There was no significant difference between the patient and the control groups with respect to cumulative survival. Of the three factors that affected survival within the patient group, aggravated oxygen demand was the only risk factor that was associated with mortality.
and a patent ductus arteriosus (PDA) 1) . Congenital heart dis ease (CHD) also occurs commonly in premature infants 2, 3) .
The presence of CHD generally causes pulmonary overflow, which alters the peripheral pulmonary arterial pressure and increases pulmonary vascular resistance. CHD can cause pul monary hypertension (PHT), which is a major cardiovascular complication that has a mortality rate that can be as high as 40%
in premature infants 1, 4, 5) . However, when PHT accompanies BPD, a cardiac shunt lesion can function as a safety device to protect against decompressive lesions 6, 7) by relieving the burden on the right side of the heart and reducing the chances of heart failure in these patients. Therefore, we hypothesized that CHD could influence the longterm BPD outcomes in premature infants.
Muneuchi et al. 8) described a case of postoperative PHT after CHD repair and addressed the appropriate periods of inter vention or treatment of CHD in BPD patients. Recently, Choi et al. 9) reported that even minor shunt lesions in premature infants with BPD, for example, atrial shunts, significantly increased PHT.
Thus, they proposed close monitoring of minor shunt lesions in premature infants with BPD.
While many recent studies have reported the longterm outcomes from premature infants with BPD alone, few have examined the longterm outcomes from premature infants with BPD and CHD 9) . Therefore, the purpose of this study was to further investigate the natural courses and prognoses of premature infants with BPD and CHD.
MATERIALS AND METHODS
We retrospectively reviewed the medical records of preterm infants with BPD and CHD who were admitted to the neonatal .
The initial diagnoses of CHD and PHT were made at a gesta tional age of 36 weeks using twodimensional transthoracic echocardiography. Pulmonary hypertension was defined as a high pulmonary arterial systolic pressure that was more than 50% of the systemic pressure and it was estimated using Doppler echocardiography, or a flat interventricular septum that was demonstrated by twodimensional echocardiography. Patients who had patent foramina ovalia and a variety of functional cardiac lesions, for example, physiological pulmonary artery stenosis or functional mitral regurgitation, were excluded from the CHD group, but they were included in the control group.
Since the purpose of our study was to observe the longterm outcomes from preterm infants with BPD and CHD, we excluded those patient who had followup durations of less than 6 months;
hence, patients with insufficient followup data were excluded from both the patient and the control groups. Patients who had expired before a gestational age of 36 weeks, which is the time at which BPD and CHD were evaluated, were also excluded from our study.
Of 167 preterm infants who were diagnosed with BPD, 45 had BPD with CHD and they were assigned to the patient group, and 79 had BPD without CHD and they were assigned to the control group. A total of 43 preterm infants were excluded either because their followup data were of poor quality or because their follow cluding tetralogy of Fallot (ToF), or a shunt with a pulmonary stenosis. PHT was investigated using twodimensional echocar diography and it was defined as an estimated pulmonary arterial pressure of greater than 50% of the systemic arterial pressure 5) .
The estimated pulmonary arterial pressure was calculated by applying the Bernoulli equation and using the measured tri cuspid regurgitation velocity or the shunt velocity. Otherwise, a flat or leftdeviated interventricular septum was defined as PHT 11, 12) .
The date of followup PHT was selected among the date of death, last echocardiography evaluation, and last visit to the outpatient clinic. The followup PHT was confirmed by the result of echocardiography performed at the last day among them. We determined which cardiac interventions were performed, the presence of aggravated oxygen demand, the persistence of PHT, and the use of pulmonary vasodilators from the medical records. 
RESULTS

Characteristics of the patient group and follow-up data
Of the 45 subjects in the patient group, 28 (62.2%) were male.
The mean gestational age of the patient group was 26. PHT was detected in nine patients, of whom three had pre tricuspid shunts and six had posttricuspid shunts. Based on the followup data, PHT was present in seven patients, of whom three patients were being followed up for CHDs and four patients had newly developed PHT, and aggravated oxygen demand was detected in six (13.3%) patients (Table 1) .
Comparison between the patient and control groups
No significant differences were observed between the patient and the control groups. The control group had a younger gesta tional age, and initial PHT was found more frequently in the patient group (Table 2 ). The KaplanMeier cumulative survival curve showed slightly worse survival in the patient group com pared with the control group, a difference that was not statistically significant (P=0.426) (Figure 2 ).
Differences in various groups of patients
When we compared the patients who died (n=6) with those who survived (n=39) with respect to their clinical characteristics, we observed that followup PHT (P=0.003), the use of pulmonary vasodilators (P<0.001) and aggravated oxygen demand during Abbreviations: CHD, congenital heart disease; ASD, atrial septal defect; PDA, patent ductus arteriosus; VSD, ven tricular septal defect; TOF, tetralogy of Fallot; PA, pulmonary atresia; PHT, pulmonary hypertension.
studies have been conducted that have investigated the natural courses of premature infants with BPD and CHD that have in cluded all of the types of CHD. In our study, we included all of the types of CHD, and these were classified anatomically. PHT asso ciated with BPD is a wellknown risk factor for mortality 1) .
The CHDs were classified anatomically, which causes differ ences in the incidence of PHT. In general, a pretricuspid shunt does not result in PHT until a later age, but a post-tricuspid shunt is likely to cause PHT, even at an early age 13, 14) . An obstructive the followup period were more frequently detected in the pa tients who died (P<0.001) ( Table 3 
Risk factors for mortality
A multivariate analysis was performed to identify the risk fac tors associated with mortality in premature infants with BPD and CHD. Mortality was more than 207times higher in the pre sence of aggravated oxygen demand, and it was the only stati stically significant risk factor that was related to mortality (Table 4) .
DISCUSSION
Our investigation showed that longterm survival in premature infants with BPD and CHD was similar to that in premature infants with BPD only. We also determined that the presence of PHT and the type of CHD did not affect mortality in premature infants with BPD. To the best of our knowledge, no longterm The data presented are the means±standard deviations, unless other wise specified. Abbreviations: CHD, congenital heart disease; BPD, bronchopul monary dysplasia; PHT, pulmonary hypertension.
Figure 2.
The Kaplan-Meier survival curve showed worse survival for the patient group, which was defined as preterm infants with bronchopulmonary dysplasia (BPD) and congenital heart disease (CHD), relative to the control group, which was defined as preterm infants with BPD only, but the difference was not statistically significant. Abbreviations: CHD, congenital heart disease; BPD, broncho pulmonary dysplasia; F/U, follow-up. . In cases with posttricuspid shunt lesions, the incidence of PHT Abbreviations: Exp (B), odds ratio; CI, confidential interval; BPD, bronchopulmonary dysplasia; CHD, congenital heart disease; PHT, pulmonary hypertension. curves based on the presence of each of the vari ables in patients with bronchopulmonary dysplasia and congenital heart disease showed that the existence of initial and follow-up pulmonary hypertension, the use of pulmonary vasodilators, and the presence of aggravated oxygen demand had significant effects on patient survival. Abbreviations: CHD, congenital heart disease; ASD, atrial septal defect; PDA, patent ductus arteriosus; VSD, ventricular septal defect; PHT, pulmonary hypertension; F/U, follow-up.
varies according to the sizes of the defect and the shunt lesion.
The posttricuspid shunt lesions in our study were usually of restrictive sizes, and one VSD closure was performed during the followup period.
Choi et al. 9) reported that pretricuspid atrial shunt lesions resulted in a greater incidence of PHT in premature infants with BPD and that they could increase mortality in this group.
In our study, the posttricuspid shunt group included a greater proportion of patients with initial PHT compared with the pre tricuspid shunt group (Table 5) . However, there was no difference between the groups in relation to survival, but, despite this, the posttricuspid shunt group required more comprehensive management because of the greater frequency of PHT.
In cases of CHD that involve shunt lesions, persistent pul mo nary overflow can develop, which increases pulmonary vas cular resistance. This causes the pulmonary vasculature system to undergo oxidative stress and to become inflamed 15, 20) . Endothelial cell dysfunction, abnormal shear stresses, and imbalance in the vasoactive mediators may occur, which may then contribute to vasoconstriction, cell proliferation, and im paired apoptosis in the pulmonary vasculature. The media and the adventitia of the small pulmonary arteries become hyper trophic, and they thicken and fibrosis develops, which results in lung vasculature narrowing and increases in pulmonary vascular resistance 16, 2123) . In this study, we could not easily predict the effects of CHD that involved shunt lesions, because the majority of the CHDs in our patient group were mild. Although a small shunt lesion can contribute to the development of PHT, as noted in a recent study 9) , the effect is difficult to quantify. On the other hand, the presence of an obstructive lesion, such as ToF, can also affect the development of the pulmonary artery 24) . We deduced that this could, hypothetically, increase pulmonary vascular resistance, leading to PHT. In this study, however, no significant differences was observed among the patients who were categorized according to the anatomical classification of their CHD in relation to followup PHT.
Our classification of CHD in this study was very arbitrary and it was the topic of several discussions. An alternative classification could have been used that was based on the amounts of pul monary blood flow, namely, overflow versus underflow; however, there was a large difference with respect to the number of patients (39 vs. 6) and some of the patients with ToF showed high oxygen saturation levels that were over 90% in the intensive care unit. In spite of these problems, it did not show a statistical significance in the univariate analysis when we included it in the risk analysis (P=0.896)
PHT should be detected using echocardiography and con firmed using cardiac catheterization. However, when consider ing a patient's characteristics, an accurate diagnosis is often . It is well known that pulmonary vasodilators induce pulmonary vasodilation, so they could be harmful to patients with systemictopulmonary shunt lesions, because of increases in the pulmonary blood flow. However, as a consequence of the restrictive shunt lesions in our patients, PHT was considered in the presence of BPD. Although unclear, the lower survival rate in the patients who used pulmonary vasodilators may not have been a consequence of their use, but rather a consequence of PHT caused by BPD and CHD.
In this study, severe BPD signified the state of lungs at a gestational age of 36 weeks, and this can improve with increasing age. However, increased oxygen demand signified the aggravated state of the lungs, which included the aggravated BPD as well as the continuous destruction of the lung fields caused by the different underlying etiologies that aggravate PHT. We assumed There are some limitations to our study. First, this was a re trospective study, and the cohort size was small. We largely depended on the patients' previous medical records, and the low mortality rate weakened the statistical significance. Moreover, most of the CHDs in our patients were mild forms of shunt lesions; therefore, the hemodynamic effects on the pulmonary vascularity were not great and the impact on survival may have 
CONCLUSION
In our study, CHD in premature infants with BPD did not significantly affect the survival rate compared with that of premature infants with BPD alone. Since the presence of cardiac shunt lesions in premature infants with BPD was associated with the development of initial PHT, early assessments and interventions in CHD are warranted.
